Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Apr 22, 2024 (2 years ago)

Schwinnng Herbal Dietary Supplement Capsules

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Marketed Without An Approved NDA/ANDA

Cause type: Unapproved drug

The product was marketed without an approved NDA/ANDA, or does not meet the OTC monograph it claims to follow. Nothing about the product - dose, purity, safety - has been reviewed by FDA, so the claims on the box are unverified. All unapproved drug recalls.

What was recalled

Schwinnng Herbal Dietary Supplement Capsules, packaged in 10-count boxes, distributed by VSD Productions Inc., Las Vegas, NV.

Recalling firm
Stop Clopez Corp
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
Company announcement
Apr 22, 2024 · FDA notice with lot numbers
FDA recall number
D-0494-2024 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other unapproved drug recalls from 2024

All unapproved drug recalls
Class II · Moderate risk

Ramipril Capsules USP 10 mg

CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor

Terminated Unapproved drug Lupin Pharmaceuticals Inc. NDC 68180-591-09 D-0054-2025
Class II · Moderate risk

Ramipril Capsules USP 5 mg

CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor

Terminated Unapproved drug Lupin Pharmaceuticals Inc. NDC 68180-590-09 D-0053-2025
Class II · Moderate risk

Ramipril Capsules USP 2.5 mg

CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor

Terminated Unapproved drug Lupin Pharmaceuticals Inc. NDC 68180-589-09 D-0052-2025
Class I · High risk

Neptune's Fix

Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.

Terminated Unapproved drug Super Chill Products D-0393-2024